FDA and Panalba: a conflict of commercial, therapeutic goals?
D004339:Drug Compounding; D004345:Drug Industry; D004994:Ethics, Pharmacy; D007880:Legislation, Drug; D009675:Novobiocin; D011057:Politics; D013752:Tetracycline; D014481:United States; D014486:United States Food and Drug Administration
D009675:Novobiocin; D013752:Tetracycline